Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Chondrosarcoma × nilotinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Retroperitoneal liposarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Chondrosarcoma 1

Interventions

Doxorubicin 2 spartalizumab 1 nilotinib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 envafolimab 1 Trabectedin 1 TQ-B3525 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Heavy Ion Radiotherapy 1 Gelclair 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02587169 2015-10-27

GEIS-27

Broto, Javier Martín, M.D.

Phase 1/2 Unknown

Retroperitoneal liposarcoma, Chondrosarcoma, Leiomyosarcoma, Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡